ATLASParabilis Medicines (PBLS) earnings date: Nov 12, 2026
Parabilis Medicines (PBLS) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of -$0.40.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PBLS
| Last price | $28.32 (-1.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.4% |
These figures come from the same calibrated model and valuation as the Parabilis Medicines stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Parabilis Medicines reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Parabilis Medicines. You can switch it off at any time.
Alert me before PBLS reportsFree to start. Creating an account takes under a minute.
PBLS earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.40 |
| Last report | Aug 13, 2026 · Miss |
| Average EPS surprise | -389.5% |
| Sector | Healthcare · Biotechnology |
Parabilis Medicines earnings history: last 2 reports
Parabilis Medicines last reported on Aug 13, 2026: EPS of -$2.12 against an estimate of -$0.24 (-783.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.24 | -$2.12 | -783.3% | Miss | -0.9% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +6.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PBLS
See the fair value, the probability range and the earnings history of Parabilis Medicines on its ATLAS page.
Parabilis Medicines (PBLS) stock analysisPlans from €3.99 a month.
Parabilis Medicines earnings: frequently asked questions
When does Parabilis Medicines (PBLS) report earnings?
Parabilis Medicines is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PBLS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.40 per share (USD). Estimates can change before the report.
Did Parabilis Medicines beat earnings estimates last quarter?
Parabilis Medicines last reported on Aug 13, 2026: EPS of -$2.12 against an estimate of -$0.24 (-783.3% surprise), a miss.
How much does PBLS usually move in a day?
On a normal trading day the ATLAS model puts PBLS’s one-day range at about ±4.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer